COMMENTARY

• Hardships and Successes of Diversified Entrants Lead to Question: Will Pharmaceuticals Continue to Be a Growth Sector?
  March 5, 2014

• Revised JCS Guidelines Clarify Role of Novel Oral Anticoagulants in Patients with Atrial Fibrillation
  February 12, 2014

• Will JPWA’s Move to Integrate Tax Display Method Dispel Medical Institutions’ Misconception?
  January 31, 2014

• FY2014 May Be Year 1 of New Reform Era; Drug Makers Need to “Turn Calamity into Good Fortune”
  January 7, 2014

• First SGLT-2 Inhibitor Set to Debut Next April; Curtain Rising on “Unprecedentedly Competitive” Market
  December 18, 2013

• Bearing “Edo” in Its Name, Japan-Originated Edoxaban Set to Challenge Rival Anticoagulants in World Market
  December 6, 2013

• MHLW Shocks Generic Drug Industry by Proposing “50% Rule,” Expansion of Uniform Pricing
  November 19, 2013

• Range of Drugs Eligible for Premium for New Drug Development May Be Reviewed; Industry Needs to Dispel Suspicions
  November 13, 2013

• Interim Report of Diovan Committee Raises Further Questions
  October 15, 2013

• Remicade Biosimilar Debut Awaited in FY2014; Good Opportunity to Revisit Healthcare Finance?
  October 4, 2013

• Comprehensive Review of Package Inserts to Begin with Effort to Identify Inconsistencies Between Inserts for Similar Drugs
  August 27, 2013

• Transparency Guidelines Go Live, Will It Help Pharmas Win Public Trust?
  August 2, 2013

• Overseas Outlook Will Be Essential to Survival and Progress of Domestic CROs
  June 24, 2013

• PMDA’s Seriousness About Becoming a Leading Global Regulatory Authority to Be Tested
  May 30, 2013

• Beyond Risk Management: RMPs Provide Opportunity for Post-Marketing Drug Development and Product Differentiation
  May 8, 2013

• Iressa Cases Signal Risks Hiding in Daily Clinical Practices
  April 22, 2013

• Will Drugs that Fight Cancer Stem Cells Succeed? Domestic Clinical Trial by DSP on the Horizon
  March 15, 2013

• Gov’t, Industry to Support Developing Countries through Development of Drugs for Infectious Diseases; Hoping to Secure Future Business Opportunities as Well
  February 27, 2013

• What Next for a “Mature” ICH? What More Can Be Done Beyond Regulatory Harmonization?
  January 22, 2013

• Hot Products in 2013: New Drugs Likely to Jolt RA Treatment, Anticoagulant Markets
  January 8, 2013

ページ